Repeated Administration of High Dose Depot Medroxy Progesterone Acetate does not Alter SHIVSF162p3 Viral Kinetics and Tenofovir Pharmacokinetics when Delivered via Intravaginal Rings
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i

Repeated Administration of High Dose Depot Medroxy Progesterone Acetate does not Alter SHIVSF162p3 Viral Kinetics and Tenofovir Pharmacokinetics when Delivered via Intravaginal Rings

Filetype[PDF-510.23 KB]


  • English

  • Details:

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov